Focused on biopharmaceutical innovation, safeguarding the future of human health.
HANGZHOU PHAGEPHARM MEDICAL TECH Co., Ltd. focuses on the industrial R&D and production of human-use bacteriophages. The company has established one of China’s leading industrial R&D technology platforms for human-use phages, as well as an enterprise-level human-derived bacterial and phage strain bank.
Based on its phage technology platform, Nuoan Baihui has developed an integrated phage cocktail solution and customized service system covering diagnosis, prevention, and treatment. With human-use phage products at the core, the company is also expanding into multiple application scenarios, including cosmetics, gastrointestinal health, women’s intimate care, and hospital disinfection and infection control.
In addition, Nuoan Baihui provides brand owners and OEM partners with compliant, standardized raw materials, efficacy data, formulation recommendations, and joint product development support.
Expert R&D Team
Innovative Technology Platform
Rigorous Quality Control
Phage & Bacterial Strain Bank
4 Technology Platforms 20 Standard Bacterial Species 6,055 Bacterial Strains 2,969 Phage Isolates
Team of experts
Attracting top talents and leading technological innovation